Long-term carvedilol therapy increases parasympathetic nervous system activity in chronic congestive heart failure

Am J Cardiol. 1997 Oct 15;80(8):1101-4. doi: 10.1016/s0002-9149(97)00616-4.

Abstract

To determine the effect of beta blockade on parasympathetic nervous system activity, we assessed RR variability during 24-hour Holter monitoring in 10 patients with congestive heart failure before and after 3 to 4 months of treatment with the beta blocker carvedilol. High-frequency power increased from 26 to 64 ms2, root-mean-square of successive differences in RR interval increased from 14.3 to 23.7 ms2, and percentage of absolute differences >50 ms between successive normal RR intervals increased from 0.8% to 4.7%, all p <0.01, indicating a substantial increase in parasympathetic modulation of RR intervals.

MeSH terms

  • Adrenergic beta-Antagonists / administration & dosage
  • Adrenergic beta-Antagonists / pharmacology*
  • Adrenergic beta-Antagonists / therapeutic use
  • Adult
  • Aged
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Carbazoles / administration & dosage
  • Carbazoles / pharmacology*
  • Carbazoles / therapeutic use
  • Carvedilol
  • Chronic Disease
  • Digoxin / therapeutic use
  • Electrocardiography / drug effects*
  • Female
  • Heart Failure / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Parasympathetic Nervous System / drug effects*
  • Propanolamines / administration & dosage
  • Propanolamines / pharmacology*
  • Propanolamines / therapeutic use

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Carbazoles
  • Propanolamines
  • Carvedilol
  • Digoxin